Women's Health

Earlier Hormone Therapy May Pose Less Risk for Menopausal Women

Headlines in Reproductive Medicine October 01, 2015

Women who start hormone therapy toward the beginning of menopause may have a lower risk of developing heart disease, new research suggests.

Human Reproduction, Health Broadly Damaged by Toxic Chemicals: Report

Headlines in Reproductive Medicine October 01, 2015

Among the poor health outcomes linked to pesticides, air pollutants, plastics and other chemicals, according to the report from the International Federation of Gynecology and Obstetrics (FIGO), an organization representing obstetrical and gynecological associations from 125 countries, are miscarriage and still births, an increase in cancer, attention problems and hyperactivity.

Want to Fight Poverty? Expand Access to Contraception

Headlines in Reproductive Medicine September 30, 2015

Pope Francis’s visit has brought renewed attention to some of our nation’s toughest economic challenges: inequality, poverty and income (im)mobility.

Planned Parenthood President Grilled at House Hearing

Headlines in Reproductive Medicine September 30, 2015

Republicans accused Planned Parenthood President Cecile Richards on Tuesday of spending $40 million on "lavish" priorities during a heated and emotional congressional hearing on the embattled organization.

If Menopause Gives You Hot Flashes, New Report Shows What Helps, What Doesn't

Headlines in Reproductive Medicine September 24, 2015

After reviewing the medical literature on non-hormonal hot flash treatments, experts at the North American Menopause Society have weighed in with a report published Wednesday. The downside? The list of treatments that have NOT been proven to work is longer than the list of those that do — and the news may leave many women unhappy.

The Affordable Care Act is Great for Women of Reproductive Age

Headlines in Reproductive Medicine September 23, 2015

A report from the Guttmacher Institute found that the proportion of women between the ages of 15 and 44 without insurance dropped by 22 percent in the ACA’s first year. Between 2013 and 2014, the percentage decreased from 17.9 percent to 13.9 percent, according to the report, which was released on Tuesday. That was largely a result of increased Medicaid coverage under the act, which saw a 17.4 percent increase among women of reproductive age.

FDA to Review Safety of Controversial Women’s Sterilization Device

Headlines in Reproductive Medicine September 23, 2015

On Thursday, the Food and Drug Administration will hold a public hearing to consider the stories of women like Hughes, who claim they have been seriously harmed by the permanent birth-control device. The agency called the meeting earlier this year amid mounting reports of complications linked to the device — more than 5,000 at last count — and a long-running social media campaign by women who want Essure pulled from the market.

Comments from ASRM and SART on “Outcomes of Fresh and Cryopreserved Oocyte Donation”

Press Releases August 11, 2015

James Toner, MD, SART President remarked, “We appreciate Dr. Kushnir and his colleagues’ sharing their analysis comparing the outcomes of cycles using frozen donor eggs with outcomes of fresh donor egg cycles. This year, for the first time, SART included frozen donor egg cycles in its National Report, enabling this large-scale, nationwide comparison to be done. 

FDA’s Obstetrics and Gynecology Devices Panel Will Meet on September 24, 2015 to Discuss the Essure System

ASRM Bulletins July 29, 2015

The OB/Gyn Devices Panel of FDA’s Medical Devices Advisory Committee is convening to seek expert scientific and clinical input on the risks and benefits of Bayer HealthCare’s Essure System for permanent female sterilization.

Highlights from Fertility and Sterility: Washing Ovarian Follicles Effectively Removes Contaminating Malignant Cells

Press Releases June 11, 2015

Belgian researchers have found that a triple-wash technique is effective for cleansing antral follicles (egg-containing cells) isolated from ovarian tissue contaminated with malignant cells, while maintaining the follicles’ viability.  This is an essential step in developing a process to preserve fertility for young girls who must undergo chemotherapy to treat childhood cancer, particularly leukemia.

Back to Top